CADx Lung Risk Score Decomposition for Clinical Explicability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current Computer Aided Diagnosis (CADx) systems for lung cancer risk assessment, particularly those using deep neural networks, lack explicability, making it difficult for clinicians to understand and trust the predictive scores due to the complexity of the models and inability to assess the contribution of known predictors.

Innovation Solution

A method and system that decompose the risk score into contributions from known predictors, allowing clinicians to understand how the model arrived at the score by correlating features with specific predictors, using a neural network and a loss function that enforces non-zero contributions for known features to match clinical knowledge.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deep neural networks are used for lung cancer risk assessment, then predictive accuracy is improved, but explicability deteriorates

Engineering Contradiction:
Improvepredictive accuracyVSAvoidexplicability
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent segments the feature descriptor into multiple feature groups, where each group is associated with a specific known predictor (e.g., size, shape, texture). This segmentation allows the system to maintain the predictive power of deep neural networks while providing explicability by showing which known predictors contribute to the risk score. The feature groups act as intermediaries that bridge the gap between complex model internals and clinically interpretable features.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If complex machine learning models are used, then predictive performance is improved, but device complexity increases

Engineering Contradiction:
Improvepredictive performanceVSAvoidmodel complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces feature groups as intermediary structures between the complex neural network and the clinical interpretation layer. Each feature group serves as a mediator that aggregates multiple features and associates them with known predictors. This intermediary structure allows the complex model to maintain its predictive performance while presenting a simplified, interpretable interface to clinicians through the mapping to known predictors.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of information

If features are decomposed into groups associated with known predictors, then explicability is improved, but computational complexity increases

Engineering Contradiction:
ImproveexplicabilityVSAvoidcomputational complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent performs preliminary grouping of features during the model training phase, organizing features into groups associated with known predictors before making predictions. This preliminary action allows the explicability structure to be established in advance, so that during inference, the system only needs to retrieve and aggregate pre-grouped features rather than performing complex decomposition calculations in real-time.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12112852B2CAD device and method for analysing medical images
Publication Date: 2024.10.08 OPTELLUM LTD
  • US12112852B2 patent drawing
  • US12112852B2 patent drawing
  • US12112852B2 patent drawing

AI summary

A method for providing a lung disease risk measure in a Computer Aided Diagnosis system is described. The method comprises the steps of: receiving an input comprising at least one input image showing all or part of the lungs of a patient; analysing the input to identify a feature descriptor comprised of at least one feature group, where each feature group comprises at least one feature computed from the input image; calculating a score explanation factor for each feature group, and an overall disease risk score for the patient's risk of lung disease from the feature descriptor; outputting the overall disease score risk score and a corresponding score explanation factor for each feature group. A computer aided diagnosis system is also described, along with a method for training a computer aided diagnosis system.